-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FWtwMdhYv5ZUYxsUrsNo3CFkU3MHnJKTYNeyXS1DWn0J/JBDLJkZqPUKEy3HzQFu HmC2cUjkc+8uJpxcamVx+Q== 0001193125-03-004596.txt : 20030513 0001193125-03-004596.hdr.sgml : 20030513 20030513110452 ACCESSION NUMBER: 0001193125-03-004596 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20030513 ITEM INFORMATION: Financial statements and exhibits ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20030513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 03694313 BUSINESS ADDRESS: STREET 1: 11100 MEAD ROAD STE 300 CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 11100 MEAD ROAD STE 300 CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 8-K 1 d8k.txt FORM 8-K U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K - -------------------------------------------------------------------------------- CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 13, 2003 AMEDISYS, INC. -------------- (Exact Name of Registrant as Specified in Charter) Delaware -------- (State or Other Jurisdiction of Incorporation or Organization) 0-24260 11-3131700 -------- ---------- (Commission File Number) (I.R.S. Employer Identification No.) 11100 Mead Road, Suite 300, Baton Rouge, LA 70816 ------------------------------------------------- (Address of principal executive offices including zip code) (225) 292-2031 -------------- (Registrant's telephone number, including area code) ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (a) Financial Statements of Business Acquired. Not applicable. (b) Pro Forma Financial Information. Not applicable. (c) Exhibit No. 99.1 (i) Press Release dated May 13, 2003 announcing the Company's first quarter 2003 operating results 99.2 (i) Certification of William F. Borne, Chief Executive Officer 99.3 (i) Certification of Gregory H. Browne, Chief Financial Officer (i) Filed herewith. ITEM 9. REGULATION FD DISCLOSURE On May 13, 2003, Amedisys, Inc., "the Company", issued a press release attached hereto as Exhibit 99.1 releasing first quarter 2003 operating results. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMEDISYS, INC. By: /s/ Gregory H. Browne ------------------------ Gregory H. Browne Chief Financial Officer DATE: May 13, 2002 EX-99.1 3 dex991.txt PRESS RELEASE Exhibit 99.1 Contact: Amedisys, Inc. EURO RSCG Life Chief Financial Officer Investors/Media Greg Browne John Capodanno 225.292.2031 212.845.4258 gbrowne@amedisys.com john.capodanno@nrp-euro.com AMEDISYS REPORTS FIRST QUARTER NET INCOME OF $0.12 PER SHARE COMPANY TO HOST CONFERENCE CALL TODAY AT 10:00 AM EDT BATON ROUGE, Louisiana (May 13, 2003) - Amedisys, Inc. (Nasdaq: "AMED" or the "Company"), one of America's leading home health nursing companies, today reported its financial results for the first quarter of 2003. For the three months ended March 31, 2003, the Company recorded revenues of $31.1 million, compared with $31.9 million in the first quarter of 2002. Pretax income totaled $1.9 million in the most recent quarter, versus pretax income of $2.6 million in the prior-year period. Net income of $1.1 million, or $0.12 per diluted share, was recorded in the first quarter of 2003, versus net income of $4.0 million or $0.52 per diluted share, in the year-earlier quarter. The prior year included a benefit related to the elimination of the valuation allowance for net deferred tax assets of $1.4 million, whereas for fiscal 2003, the Company recorded an income tax expense of $0.7 million. "We are very pleased that the operational restructuring work undertaken in response to recent Medicare reimbursement changes has achieved our expectation of margin improvement, and expense reduction." commented William F. Borne, Chief Executive Officer. "Our results for the recently completed quarter were consistent with both the earnings, and other guidance, previously communicated, and we remain comfortable with full year estimates of between $0.50 and $0.60 cents per share," "Same-store Medicare patient admissions for the most recent quarter grew by 7 percent when compared with the strong first quarter of 2002, and our utilization of nursing resources has continued the improvement seen over the previous twelve months. These improvements, when combined with the reduction in private insurance related revenue, and a restructuring of clinical management, have resulted in a significant improvement in gross margin to 58.5 percent in the first quarter, compared with 56.5 percent in the comparable period of 2002. The two percent decrease in revenue from 2002, despite the strong admission growth referred to above, is attributable to the Medicare reimbursement reduction effective October 1, 2002, and in part to the additional cut effective April 1, 2003. "The Company reduced its debt by a net $2.1 million during the quarter ended March 31, 2003, and ended the quarter with cash of over $8.3 million, an increase of $3.5 million from December 31, 2002. This improvement in our cash position as a result of both continued profitability, and improvements in working capital, has presented the Company with significantly greater flexibility regarding further acquisitions and balance sheet enhancements," concluded Mr. Borne. The Company will provide further information today on these results during a teleconference call that is scheduled for 10:00 a.m. EDT. To access this call, please dial 1-888-896-0863 (domestic), or 1-973-582-2703(international) a few minutes before 10:00 a.m. EDT. A replay of the conference call will be available until May 23, 2003, by dialing 1-877-519-4471 (domestic), or 1-973-341-3080 (international). The Access Code is #3883267 for the replay. Amedisys, Inc., a leading provider of home health nursing services, is headquartered in Baton Rouge, Louisiana. The Company had approximately $129 million in revenue in 2002. Its common stock trades on the Nasdaq Stock Market under the symbol "AMED". This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. Additional information on this Company can be found on the World Wide Web http://www.amedisys.com AMEDISYS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS For the three months ended March 31, 2003 and 2002 (Unaudited, Dollar amounts in 000's, except per share data)
Three months ended March 31, 2003 March 31, 2002 ---------------- ---------------- Net service revenue $ 31,132 $ 31,850 Cost of service revenue 12,909 13,869 ---------------- ---------------- Gross margin 18,223 17,981 ---------------- ---------------- General and administrative expenses: Salaries and benefits 9,861 9,431 Other 6,178 5,557 ---------------- ---------------- Total general and administrative expenses 16,039 14,988 ---------------- ---------------- Operating income 2,184 2,993 ---------------- ---------------- Other income and expense: Interest income 17 18 Interest expense (360) (578) Other income, net 10 131 ---------------- ---------------- Total other expense, net (333) (429) ---------------- ---------------- Income before income taxes 1,851 2,564 Income tax expense (benefit) 702 (1,438) ---------------- ---------------- Net income $ 1,149 $ 4,002 ================ ================ Basic weighted average common shares outstanding 9,327,000 7,241,000 Basic net income per common share $ 0.12 $ 0.55 ================ ================ Diluted weighted average common shares outstanding 9,501,000 7,768,000 Diluted net income per common share $ 0.12 $ 0.52 ================ ================
The accompanying notes are an integral part of these consolidated financial statements. AMEDISYS, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS As of March 31, 2003 and December 31, 2002 (Dollar amounts in 000's)
March 31, 2003 December 31, 2002 ----------------- ----------------- (unaudited) ASSETS: CURRENT ASSETS: Cash and cash equivalents $ 8,341 $ 4,861 Patient accounts receivable, net of allowance for doubtful accounts of $2,309 at March 2003 and $1,865 at December 2002 10,227 13,467 Prepaid expenses 1,929 1,600 Deferred income taxes 2,080 1,803 Inventory and other current assets 1,092 857 ----------------- ----------------- Total current assets 23,669 22,588 Property and equipment, net 7,815 8,257 Deferred income taxes 774 1,711 Other assets, net 25,748 25,768 ----------------- ----------------- Total assets $ 58,006 $ 58,324 ================= ================= LIABILITIES AND STOCKHOLDERS' EQUITY: CURRENT LIABILITIES: Accounts payable $ 1,776 $ 2,495 Accrued expenses: Payroll and payroll taxes 6,437 6,504 Insurance 2,112 2,171 Income taxes 458 297 Legal settlements 2,181 1,887 Other 2,435 2,439 Current portion of long-term debt 3,970 3,903 Current portion of obligations under capital leases 2,561 2,476 Current portion of Medicare liabilities 8,617 8,948 ----------------- ----------------- Total current liabilities 30,547 31,120 Long-term debt 3,674 4,474 Obligations under capital leases 534 1,042 Long-term Medicare liabilities 3,328 3,898 Other long-term liabilities 826 827 ----------------- ----------------- Total liabilities 38,909 41,361 STOCKHOLDERS' EQUITY: Preferred stock (none outstanding) - - Common stock (9,411,725 and 9,167,976 shares issued at March 31, 2003 and December 31, 2002, respectively) 9 9 Additional paid-in capital 30,424 29,439 Treasury stock at cost (4,167 shares of common stock held at March 31, 2003 and December 31, 2002) (25) (25) Retained earnings (deficit) (11,311) (12,460) ----------------- ----------------- Total stockholders' equity 19,097 16,963 ----------------- ----------------- Total liabilities and stockholders' equity $ 58,006 $ 58,324 ================= =================
The accompanying notes are an integral part of these consolidated financial statements. EX-99.2 4 dex992.txt CERTIFICATION OF CHIEF EXECUTIVE OFFICER Exhibit 99.2 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Current Report of Amedisys, Inc. (the "Company") on Form 8-K dated May 13, 2003 (the "Report"), I, William F. Borne, Chief Executive Officer of the Company, certify that: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. /s/ William F. Borne _____________________________ William F. Borne Chief Executive Officer May 13, 2003 EX-99.3 5 dex993.txt CERTIFICATION OF CHIEF FINANCIAL OFFICER Exhibit 99.3 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Current Report of Amedisys, Inc. (the "Company") on Form 8-K dated May 13, 2003 (the "Report"), I, Gregory H. Browne, Chief Financial Officer of the Company, certify that: (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. /s/ Gregory H. Browne _______________________________ Gregory H. Browne Chief Financial Officer May 13, 2003 -----END PRIVACY-ENHANCED MESSAGE-----